ArticleTranslational cancer research2020

The efficacy of ado-trastuzumab emtansine in patients with ERBB2-aberrant non-small cell lung cancer: a systematic review.

Xiu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.